News Focus
News Focus
Followers 16
Posts 4589
Boards Moderated 0
Alias Born 07/15/2002

Re: jessme post# 58435

Thursday, 11/18/2010 6:06:18 PM

Thursday, November 18, 2010 6:06:18 PM

Post# of 347009
Found Medibiotech listed in Bermuda

Vivatuxin - TNT-3

Hybridoma and Hybridomics
Chimeric TNT-3 Antibody/Murine Interferon-? Fusion Protein for the Immunotherapy of Solid Malignancies

July 2004

...To overcome these obstacles, we have developed an antibody/murine IFN-? fusion protein (chTNT-3/muIFN-?), which utilizes the tumor necrosis therapy antibody, chTNT-3, to target murine IFN-? to necrotic regions of solid tumors implanted in immunocompetent BALB/c mice. The genetically engineered fusion protein was expressed in NS0 cells using the Glutamine Synthetase Gene Amplification Expression System. After purification, the fusion protein demonstrated both antigen targeting and cytokine activities as assessed by in vitro assays which, when compared to recombinant free IFN-?, demonstrated approximately 40–45% biologic activity by two separate assay determinations. Pharmacokinetic and biodistribution studies in mice demonstrated a relatively long whole body half-life of 32 h in vivo and significant intratumoral accretion, respectively.

http://www.liebertonline.com/doi/abs/10.1089/153685903322328929?journalCode=hyb.2